Press Releases
Ceapro Extends Exclusive International Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise
Ceapro Announces Next Phase of Research Collaboration with the Angiogenesis Foundation
Ceapro to Participate in the Virtual Investor Summer Spotlight Series
Ceapro Announces Results of 2023 Shareholders’ Meeting
Ceapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate Update
Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases
Ceapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue Regeneration
Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations
Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights
